Young relatives of sudden cardiac death individuals at high heart disease risk

Published on November 19, 2012 at 5:15 PM · No Comments

By Piriya Mahendra, medwireNews Reporter

Young first- and second-degree relatives of individuals who were victims of sudden cardiac death (SCD) are at a significantly increased risk for developing cardiovascular disease (CVD), research suggests.

Mattis Ranthe (Statens Serum Institut, Copenhagen, Denmark) and team say that the results of their study support the use of autopsies in all cases of young SCD and suggest that close relatives of individuals who have died would benefit from screening and preventive treatment.

They found that there were 292 cases of CVD over 11 years of follow up in the 3073 first- and second-degree relatives of 470 individuals aged 1-35 years who experienced SCD between 2000 and 2006 in Denmark.

The mortality risk for a first- or second-degree relative of an SCD individual varied significantly with age: the standardized incidence ratio (SIR) for relatives younger than 35 years was 3.53 compared with an SIR of 1.59 among those aged 35-60 years and 0.91 among those older than 60 years.

There was no significant association between first- and second-degree relatives in terms of SIR for ischemic heart disease and cardiomyopathy. However, the SIR for ventricular arrhythmia in first-degree relatives was 19.15 compared with 0 in second-degree relatives.

As reported in the European Health Journal, the SIR for any CVD given an SCD in a first-degree relative was significantly higher than that in a second-degree relative, at 1.49 versus 1.11. First-degree relatives younger than 35 years had a fourfold increase in the risk for any CVD, while second-degree relatives had more than a twofold increased risk.

"If sudden cardiac death has genetic causes then this would suggest that relatives of young SCD victims are at greater risk of heart disease than the general population and would benefit from screening to identify those at risk so that they could be given appropriate preventive treatment," said Ranthe.

"This could save a significant number of lives. However, as far as we are aware, there have been no population-based findings of this kind before, and current knowledge is limited and based on smaller descriptive studies."

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Abbott announces initiation of ABSORB IV heart stent clinical trial